🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open label randomized 24 week crossover trial assessing the trea...
Status
Completed
Location
Center of Excellence in Diabetes and Endocrinology
Start Date
2019-02-07
Trial ID
NCT03831880
Treatments Being Tested
This is an open-label, randomized, multicenter, efficacy and safety study o...
Status
Completed
Location
Children's Hospital of Orange County- Children's Clinic
Start Date
2016-12
Trial ID
NCT02968004
Treatments Being Tested
This non-interventional study will be performed by design of post-marketing...
Status
Active Not Recruiting
Location
Pfizer
Start Date
2024-06-20
Trial ID
NCT05509894
Treatments Being Tested
This is a Phase 1, single-center, open-label randomized, 2×2 crossover (Ref...
Status
Completed
Location
QPS Miami Research Associates
Start Date
2019-01-18
Trial ID
NCT03810664
Treatments Being Tested
This study is a randomized, open-label, active controlled, parallel group s...
Status
Recruiting
Location
University of California Los Angeles (UCLA) - Mattel Children's Hospital
Start Date
2026-02-01
Trial ID
NCT07226089
Treatments Being Tested
Treatment of children with growth failure due to growth hormone deficiency ...
Status
Completed
Location
Aichi Medical University Hospital
Start Date
2017-12-07
Trial ID
NCT03874013
Treatments Being Tested
The purpose of this study is to learn about the safety of Somatrogon for th...
Status
Recruiting
Location
Shivajoyti Clinic
Start Date
2025-01-30
Trial ID
NCT06587035
Treatments Being Tested
The METAB-BELGROW-LAGH study aims to prospectively evaluate the metabolic o...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-01
Trial ID
NCT07173036
Treatments Being Tested
The purpose of this study is to learn about the long-term safety and effect...
Status
Active Not Recruiting
Location
Pfizer
Start Date
2023-02-06
Trial ID
NCT05602766
Treatments Being Tested